Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|August 15, 2019
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular CancerAndreas Weiss, Flavia Adler, Alexandra Buhles, et al.
Cancer Research|August 24, 2018
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201Sébastien Jeay, Stéphane Ferretti, Philipp Holzer, et al.
The Journal of Experimental Medicine|January 25, 2012
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, Andrew A Lane, Liat Bird, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 18, 2019
Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation RegistryYasuo Okumura, Koichi Nagashima, Masaru Arai, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 5, 2021
Different Determinants of the Recurrence of Atrial Fibrillation and Adverse Clinical Events in the Mid-Term Period After Atrial Fibrillation AblationRyuta Watanabe, Koichi Nagashima, Yuji Wakamatsu, et al.
International Heart Journal|November 16, 2020
Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial FibrillationYuji Wakamatsu, Koichi Nagashima, Ryuta Watanabe, et al.
European Heart Journal|July 24, 2025
Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trialKoji Miyamoto, Koshiro Kanaoka, Kenji Yodogawa, et al.
Heart and Vessels|November 25, 2020
Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF RegistryKazuki Iso, Koichi Nagashima, Masaru Arai, et al.
Cancer Cell|July 16, 2015
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative NeoplasmsSara C Meyer, Matthew D Keller, Sophia Chiu, et al.
Heart and Vessels|September 15, 2021
Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registryKeisuke Usuda, Takeshi Kato, Toyonobu Tsuda, et al.
Pageof 16